Kennedy Capital Management’s ADMA Biologics ADMA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.71M	Sell	411,347 -266,253	-39%	-$4.2M	0.08%	345
2025 Q4	$12.4M	Buy	677,600 +133,427	+25%	+$2.25M	0.26%	140
2025 Q3	$7.98M	Buy	544,173 +117,137	+27%	+$2.01M	0.18%	212
2025 Q2	$7.78M	Buy	427,036 +17,544	+4%	+$358K	0.19%	204
2025 Q1	$8.12M	Buy	409,492 +139,840	+52%	+$2.42M	0.19%	181
2024 Q4	$4.62M	Sell	269,652 -117,157	-30%	-$2.2M	0.1%	342
2024 Q3	$7.73M	Sell	386,809 -44,324	-10%	-$689K	0.17%	211
2024 Q2	$4.82M	Buy	431,133 +185,369	+75%	+$1.56M	0.1%	333
2024 Q1	$1.62M	Sell	245,764 -288,411	-54%	-$1.58M	0.03%	555
2023 Q4	$2.41M	Sell	534,175 -256,872	-32%	-$950K	0.05%	453
2023 Q3	$2.83M	Sell	791,047 -318,038	-29%	-$1.22M	0.07%	400
2023 Q2	$4.09M	Buy	1,109,085 +400,507	+57%	+$1.48M	0.1%	333
2023 Q1	$2.35M	Sell	708,578 -1,540,893	-69%	-$5.33M	0.07%	383
2022 Q4	$8.73M	Buy	+2,249,471	New	+$6.94M	0.25%	134